COVID-19 active case findings based on self-collected saliva samples with CRISPR-Cas12a detection
- 27 April 2022
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 247 (14), 1228-1234
- https://doi.org/10.1177/15353702221090181
Abstract
COVID-19 is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus affecting the world population. Early detection has become one of the most successful strategies to alleviate the epidemic and pandemic of this contagious coronavirus. Surveillance testing programs have been initiated in many countries worldwide to prevent the outbreak of COVID-19. In this study, we demonstrated that our previously established clustered regularly interspaced short palindromic repeats (CRISPR)-Cas12a-based assay could detect variants of concern during 2021 in Thailand, including Alpha, Beta, and Delta strains as well as Omicron strain in early 2022. In combination with the newly designed saliva collection funnel, we established a safe, simple, economical, and efficient self-collection protocol for the COVID-19 screening process. We successfully utilized the assay in an active case finding with a total number of 578 asymptomatic participants to detect the SARS-CoV-2 in saliva samples. We finally demonstrated that the validation and evaluation in a large-scale setting could provide valuable information and elaborate the practicality of the test in real-world settings. Our optimized protocol yielded effective results with high sensitivity, specificity, and diagnostic accuracy (96.86%). In addition, this study demonstrates COVID-19 active case findings in low-resource settings, which would be feasible and attractive for surveillance and outbreak prevention in the future.Funding Information
- Ratchadapisek Sompoch Endowment Fund (764002-HE08)
- National Research Council of Thailand
- The Innovation Fund to fight against COVID-19
- Administration and Capital Management Unit for Enhancing the Competitiveness of The Country (N41A640077)
This publication has 26 references indexed in Scilit:
- Comparative performance of CRISPR-Cas12a assays for SARS-CoV-2 detection tested with RNA extracted from clinical specimensJournal of Virological Methods, 2021
- Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infectionEmergencias, 2021
- Machine Learning-Driven and Smartphone-Based Fluorescence Detection for CRISPR Diagnostic of SARS-CoV-2ACS Omega, 2021
- A smartphone-read ultrasensitive and quantitative saliva test for COVID-19Science Advances, 2021
- Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2Nature Communications, 2020
- Detection of severe acute respiratory syndrome coronavirus 2 and influenza viruses based on CRISPR-Cas12aExperimental Biology and Medicine, 2020
- Molecular epidemiology of the first wave of severe acute respiratory syndrome coronavirus 2 infection in Thailand in 2020Scientific Reports, 2020
- Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2The New England Journal of Medicine, 2020
- Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2Journal of Clinical Microbiology, 2020
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor bindingThe Lancet, 2020